University of California San Francisco

Dr. Garrett Roll large headshot
Garrett
Roll
MD

Associate Professor of Surgery
Division of Transplant Surgery

Address

35 Medical Center Way, #001
San Francisco, CA 94143
United States

    Biography

    Dr. Roll completed both general surgery training and the abdominal organ transplant fellowship at the University of California San Francisco. During his training, Dr. Roll spent 2 years in Dr. Holger Willenbring's laboratory investigating liver cell therapy, as well as normal and pathologic liver regeneration. After fellowship Dr. Roll moved to England to become a Senior International Fellow in Liver Transplant and Multi Organ Procurement at Queen Elizabeth Hospital, Birmingham, one of the busiest liver transplant departments in the United Kingdom. There he gained valuable experience in the blossoming field of DCD liver transplant and normothermic machine liver perfusion prior to returning to UCSF.

    Since returning to UCSF in 2015, Dr. Roll has specialized in abdominal organ transplantation for both adults and children, including liver and kidney transplant surgery from living donors, complex hepatobiliary surgery, and kidney autotransplants for intractable ureteral problems. He also performs general surgery in patients with end-stage organ disease and patients taking immunosuppression. His expertise includes using minimally invasive surgical techniques.

    Within UCSF, Dr. Roll is an investigator on several clinical trials looking at outcomes for organ transplant recipients and advance organ preservation. He has leadership roles in patient safety and quality improvement at UCSF, in addition to teaching medical students and residents in multiple forums. Outside of UCSF, he serves on the editorial board of multiple peer reviewed journals.

    Education

    Education

    Boston College, BS, Finance, 1995-1999
    Brandeis University, Post Baccalaureate, Premedical, 1999-2001
    Temple University School of Medicine, MD, 2001-2005

    Residencies

    University of California, San Francisco, General Surgery, 2005-2012

    Fellowships
    Abdominal Transplant
    Start Year
    2012
    End Year
    2014

    Board Certifications

    American Board of Surgery, General Surgery

    Clinical Expertise

    Ascites

    Bile Duct Cancer (Cholangiocarcinoma)

    Bile Duct Injuries

    Bile Duct Strictures

    Bridging Therapies to Downstage HCC in Liver Transplant Setting

    Choledochal Cysts

    Deceased Donor Organ Utilization

    Gallbladder Cancer

    Kidney Transplantation

    Laparoscopic Donor Nephrectomy

    Liver Biopsy

    Hepatocellular Carcinoma (Primary Liver Cancer)

    Liver Cysts

    Liver Metastases (Secondary Liver Cancer)

    Liver Resection

    Liver Transplantation

    Living Donor Kidney Transplantation

    Living Donor Liver Transplantation

    Normothetic Machine Liver Perfusion

    Organ Donation of Cardiovascular Death

    Pancreas Transplantation

    Pediatric Kidney Transplantation

    Pediatric Liver Transplantation

    Portal Hypertension

    Clinical Interests

    Transplantation
    HBP surgery

    Clinical Trials

    1. Related Conditions: Liver Transplant| Start Date: | End Date:
    2. Related Conditions: HIV/AIDS, Kidney Transplant| Start Date: | End Date:

    In the News

    October, 16, 2015 | UCSF Transplant Surgery

    Research Interests

    Cell therapy with hepatocytes and hepatocyte-like cells derived from stem cells.
    Role of miRNA in liver regeneration

    Normothetic machine liver perfusion

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 117
    1. Strategies to improve outcomes for hepatitis C virus/human immunodeficiency virus coinfected liver transplant candidates.
      Roll GR, Stock PG| | PubMed
    2. Biliary complications following living donor hepatectomy.
      Braun HJ, Ascher NL, Roll GR, Roberts JP| | PubMed
    3. Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.
      Braun HJ, Dodge JL, Roll GR, Freise CE, Ascher NL, Roberts JP| | PubMed
    4. Accepting multiple simultaneous liver offers does not negatively impact transplant outcomes.
      Eldeen FZ, Mourad MM, Bhandari M, Roll G, Gunson B, Mergental H, Bramhall S, Isaac J, Muiesan P, Mirza DF, Perera MT| | PubMed
    5. First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusion.
      Perera T, Mergental H, Stephenson B, Roll GR, Cilliers H, Liang R, Angelico R, Hubscher S, Neil DA, Reynolds G, Isaac J, Adams DA, Afford S, Mirza DF, Muiesan P| | PubMed
    6. The safety and efficacy of proximal splenic artery embolization after liver transplantation are still not clearly defined.
      Roll GR, Muiesan P| | PubMed
    7. Brief report: Parthenogenetic embryonic stem cells are an effective cell source for therapeutic liver repopulation.
      Espejel S, Eckardt S, Harbell J, Roll GR, McLaughlin KJ, Willenbring H| | PubMed
    8. Emesis following laparoscopic left donor nephrectomy.
      Luu HY, Ulloa JG, Roll GR, Freise CE| | PubMed
    9. Failure to achieve normal metabolic response in non-obese diabetic mice and streptozotocin-induced diabetic mice after transplantation of primary murine hepatocytes electroporated with the human proinsulin gene (p3MTChins).
      Lee RH, Roll G, Nguyen V, Willenbring H, Tang Q, Kang SM, Stock PG| | PubMed
    10. Case report of intestinal tuberculosis 6 years after simultaneous pancreas and kidney transplant.
      Ulloa JG, Parekh J, Hope C, Roll GR| | PubMed